Effects of body weight, smoking status, and sex on plasma concentrations of once-monthly paliperidone palmitate.

Our findings suggest that age, sex, smoking, or body weight may not substantially affect pharmacokinetic indices of PP1M. The high interindividual variation of plasma concentrations implies that TDM may be helpful to enhance PP1M efficacy and tolerability.